CFLAR and neoplasm: As both cFLIP isoforms are short-lived proteins subject to ubiquitination and degradation by the proteasome in tumor cells treated with different anti-tumor drugs, we then examined whether TG treatment might decrease their half-lives in HCT116 cells.